NCT00664625View on ClinicalTrials.gov

A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Chronic Hepatitis C
Interventions
DRUG

BMS-791325

Capsules, Oral, Once Daily, Single Dose

DRUG

Placebo

Capsules, Oral, Once Daily, Single Dose

Trial Locations (6)

19104

University Of Pennsylvania, Philadelphia

63110

Washington University School Of Medicine, St Louis

78215

Alamo Medical Research, San Antonio

90630

West Coast Clinical Trials, Llc, Cypress

92801

Advanced Clinical Res Inst, Anaheim

C1181

Local Institution, Buenos Aires

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00664625 - A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects | Biotech Hunter | Biotech Hunter